Winsunny Pharma’s FY101 Gains NMPA Clinical Approval for Hyperlipidemia
China-based Beijing Winsunny Pharmaceutical Co., Ltd (SHA: 601089) announced that it has received clinical approval...
Winsunny Pharma
Sichuan Gowell Pharmaceutical Wins Reversal in Forxiga Patent Infringement Case
Sichuan Gowell Pharmaceutical Co., Ltd. has secured a favorable final judgment in its appeal against...
Beijing Winsunny Pharma Plans IPO to Boost Drug Development and Production
China-based Beijing Winsunny Pharmaceutical Co., Ltd. has announced plans for an initial public offering (IPO)...